PEG-hemoglobin oxygen carrier: Will start in the next few months a Phase Ib trial in 20 patients. The study will test a once-weekly dose for each five-day cours

To devote manufacturing capacity to this trial, the Phase I trial of Lysodase in Gaucher disease will be suspended when inventory is exhausted. Lysodase and PEG-hemoglobin are produced in the same fac...